Omnipred vs. Emflaza

• Are Omnipred and Emflaza the Same Thing?
• What Are Possible Side Effects of Omnipred?
• What Are Possible Side Effects of Emflaza?
• What Is Omnipred?
• What Is Emflaza?
• What Drugs Interact with Omnipred?
• What Drugs Interact with Emflaza?
• How Should Omnipred Be Taken?
• How Should Emflaza Be Taken?

Omnipred (prednisolone acetate) Ophthalmic Suspension and Emflaza (deflazacort) are corticosteroids used to treat different conditions.

Omnipred is used to treat inflammation caused by allergies, eye infections, or any general irritation to the eye.

Emflaza is used to treat Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

Side effects of Omnipred that are different from Emflaza include temporary cloudy vision, increased sensitivity of the eyes to light, stinging/burning/itching/irritation in your eyes, increased pressure in the eyes, glaucoma, optic nerve damage, cataracts, and delayed wound healing.

Side effects of Emflaza that are different from Omnipred include Cushingoid appearance (facial puffiness), weight gain, increased appetite, upper respiratory tract infection, cough, daytime urinary frequency, male-pattern hair growth in women, excessive abdominal fat, runny or stuffy nose, skin redness, irritability, abdominal discomfort or pain, abnormal behavior, fever, back pain, rash, bruising, nausea, restlessness, nosebleed, and stretch marks.

Omnipred may interact with other drugs.

Emflaza may interact with clarithromycin, fluconazole, diltiazem, verapamil, grapefruit and grapefruit juice, efavirenz, seizure medications and pancuronium.

Common side effects of Omnipred include:

• temporary cloudy vision,
• increased sensitivity of the eyes to light,
• stinging/burning/itching/irritation in your eyes,
• increased pressure in the eyes,
• glaucoma,
• optic nerve damage,
• cataracts, and
• delayed wound healing

Common side effects of Emflaza include:

• Cushingoid appearance (facial puffiness),
• weight gain,
• increased appetite,
• upper respiratory tract infection,
• cough,
• daytime urinary frequency,
• male-pattern hair growth in women,
• excessive abdominal fat,
• runny or stuffy nose,
• skin redness,
• irritability,
• abdominal discomfort or pain,
• abnormal behavior,
• fever,
• back pain,
• rash,
• bruising,
• nausea,
• restlessness,
• nosebleed, and
• stretch marks.

Omnipred (prednisolone acetate) Ophthalmic Suspension is an adrenocortical steroid is used to treat inflammation caused by allergies, eye infections, or any general irritation to the eye.

Emflaza (deflazacort) tablets or oral suspension is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

Other drugs may interact with Omnipred. Tell your doctor all medications you take. Do not stop using Omnipred suddenly. Avoid touching the bottle tip to eyelids or to any other surface. Use of the bottle by more than one person may spread the infection. If you are pregnant only use Omnipred if the potential benefit outweighs the potential risk to the fetus. Do not use Omnipred if you are breastfeeding.

Emflaza may interact with clarithromycin, fluconazole, diltiazem, verapamil, grapefruit juice, efavirenz, carbamazepine, phenytoin, or pancuronium. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Emflaza; it is unknown how it will affect a fetus. Other corticosteroids cross the placenta and may cause birth defects. Systemically administered corticosteroids such as pass into breast milk and could cause adverse effects in a nursing infant. Consult your doctor before breastfeeding.

The recommended dosage of Omnipred is two drops in the eyes four times per day.

The recommended once-daily dosage of Emflaza is approximately 0.9 mg/kg/day administered orally.